
Indian Immunologicals Ltd (IIL), a subsidiary of the National Dairy Development Board, celebrated the 25th anniversary of its Human Biologicals Institute (HBI). Established in 1998, HBI has become a global leader in vaccine manufacturing, producing the world's largest supply of anti-rabies vaccines and key vaccines for India's immunization program. On this occasion, HBI launched MebellaM, a Measles Rubella (MR) Vaccine, and announced the upcoming release of Havisure, India's first indigenous Hepatitis A Vaccine, by March 2024, reinforcing its commitment to addressing healthcare challenges through innovative vaccines.
Like
Save
Share